152 related articles for article (PubMed ID: 32256653)
1. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
Zhao X; Hao J; Chen S
Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
[TBL] [Abstract][Full Text] [Related]
2. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
Tu H; Li J; Xu W; Wang Z; Wang L
Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
[TBL] [Abstract][Full Text] [Related]
3. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
Wu J; Luo D; Li S
Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
[TBL] [Abstract][Full Text] [Related]
5. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
[TBL] [Abstract][Full Text] [Related]
6. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
[TBL] [Abstract][Full Text] [Related]
7. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics.
Wang J; Zhang Y; Wang Q; Wang L; Zhang P
Evid Based Complement Alternat Med; 2022; 2022():4651432. PubMed ID: 35449823
[TBL] [Abstract][Full Text] [Related]
8. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
[TBL] [Abstract][Full Text] [Related]
9. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
10. The prospect of
Chen Z; Li Z; Yang S; Wei Y; An J
Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
[TBL] [Abstract][Full Text] [Related]
11. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms.
Wan Y; Xu L; Liu Z; Yang M; Jiang X; Zhang Q; Huang J
BMC Complement Altern Med; 2019 Jul; 19(1):158. PubMed ID: 31272505
[TBL] [Abstract][Full Text] [Related]
12. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Regulation Mechanism of Xihuang Pill,
Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
[TBL] [Abstract][Full Text] [Related]
14. Exploring the mechanism of Shenqisherong pill against cervical spondylotic myelopathy by network pharmacology and molecular docking.
Li G; Sun YL; Sng KS; Zheng Z; Wang YJ; Yao M; Cui XJ
Ann Palliat Med; 2021 Oct; 10(10):10253-10275. PubMed ID: 34498478
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
Yu Y; Yang F; Liu H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
[TBL] [Abstract][Full Text] [Related]
17. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
18. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways.
Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF
World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323
[TBL] [Abstract][Full Text] [Related]
19. An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
Li C; Wang Z; Chen W; Cao B; Zhang M; Gu Q; Qi S; Fei X; Shi Y; Li X; Li R; Wang J; Li G
Front Oncol; 2021; 11():697247. PubMed ID: 34434895
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism action of Chinese herbal compound and target network pharmacology of
Li M; Shi XL; Xu C; Wu LG; He B; Li YH; Liang BC
Zhongguo Gu Shang; 2020 Oct; 33(10):933-7. PubMed ID: 33107256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]